Moisturizing and repairing cream having soothing effect, and preparation method therefor

MYPI2025005273A0Undetermined Publication Date: 2024-09-07HEYLING PHARM (GUANGZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005273
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-07
Filing Date
2024-03-07
Publication Date
2024-09-07

AI Technical Summary

Technical Problem

The dry and itchy skin of patients with atopic dermatitis (AD) is difficult to effectively alleviate, and existing skin care products have limited effectiveness in inhibiting inflammatory factors and moisturizing.

Method used

A moisturizing and repairing cream containing avocado tree butter extract, licorice root extract, ceramide composition, cholesterol and linoleic acid is used, and is formed by compounding emulsifiers, emollients and skin conditioners. A thin oil film rebuilds the skin barrier, inhibits the release of inflammatory factors, and locks in moisture.

Benefits of technology

Effectively relieve itching, repair damaged skin, maintain water content in the stratum corneum, enhance skin barrier function, reduce dry skin and inflammation, and improve quality of life.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present application relates to a moisturizing and repairing cream with a soothing effect, which includes the following raw materials: Phase A: deionized water, disodium EDTA, allantoin, and p-hydroxyacetophenone; Phase A1: ammonium acryloyldimethyltaurate / VP copolymer and acrylates / C10-30 alkyl acrylate cross-linked polymer; Phase B: glyceryl stearate, M68 emulsifier, cetearyl alcohol, polydimethylsiloxane, dimethylsiloxane (and) polydimethylsiloxane / vinyl polydimethylsiloxane cross-linked polymer, olea europaea fruit oil, squalane, a skin conditioning agent, and caprylic / capric triglyceride; Phase B1: diethylhexyl carbonate and pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate; Phase C: deionized water and aminomethyl propanol; Phase D: glycyrrhiza inflata root extract and 1,2-pentanediol; Phase E: Symsitive 1609 and saccharide isomerate A0; Phase F: glycerin and glabridin 90.
Need to check novelty before this filing date? Find Prior Art

Description

Moisturizing repair cream with soothing effect and preparation method thereof

[0001] Related applications

[0002] This application claims priority to Chinese patent application No. 2023102113253, filed on March 7, 2023, entitled “A Moisturizing Repair Cream with Soothing Effect,” the entire text of which is incorporated herein by reference. Technical Field

[0003] The present application relates to a skin care product, and in particular to a moisturizing repair cream with soothing effect and a preparation method thereof. Background Art

[0004] Atopic dermatitis (AD), also known as "specific eczema," is a common chronic, recurring, inflammatory skin disease. Its pathogenesis is closely linked to genetic and environmental factors. Its most defining characteristics are dry skin, chronic eczematous dermatitis, and intense itching. Eczema is caused by a variety of inflammatory factors, and the key to its treatment lies in inhibiting their activity.

[0005] Skin biology studies have shown that defective skin barrier function is a key factor in the development of AD, and ceramide deficiency is one of the main causes of barrier function defects. Ceramide deficiency can easily lead to low water content in the stratum corneum, increased transepidermal water loss, changes in the sebaceous glands of AD, reduced lipid secretion, increased pH, and other phenomena, leading to dryness and scaling of the skin, increased density of skin sensory nerve fibers, and increased itching. Proper bathing and the use of moisturizers are very important in the treatment of AD. During an attack, topical glucocorticoids and calcineurin inhibitors are the main treatments, supplemented by medical moisturizers to reduce the severity of the disease and improve the appearance of the affected area. During the remission period, medical moisturizers can be used alone to promote skin barrier recovery, maintain disease stability, and reduce recurrence rates.

[0006] Medical moisturizing and barrier-repairing skincare products are well-tolerated. They absorb moisture from the environment, replenishing the water and lipid components lost by the stratum corneum, forming a thin oil film on the skin's surface, rebuilding the chemical and physical barriers and preventing water loss. This moisturizing and emollient effect can prevent recurrence of AD and improve quality of life. To this end, we propose a moisturizing and repairing cream with soothing properties.

[0007] Summary of the Invention

[0008] According to various embodiments of the present application, the present application provides a moisturizing repair cream with soothing effect.

[0009] In order to achieve the above objectives, this application adopts the following technical solutions:

[0010] A soothing, moisturizing and repairing cream comprising:

[0011] Phase A: deionized water, disodium EDTA, allantoin, and p-hydroxyacetophenone;

[0012] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer and Acrylates / C10-30 Alkyl Acrylate Crosspolymer;

[0013] Phase B: Glyceryl Stearate, M68 Emulsifier, Cetearyl Alcohol, Dimethicone, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, OLEA EUROPAEA FRUIT OIL, Squalane, Skin Conditioning Agents and Caprylic / Capric Triglyceride;

[0014] Phase B1: diethylhexyl carbonate and pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0015] Phase C: deionized water and aminomethyl propanol;

[0016] Phase D: Glycyrrhiza inflata root extract and 1,2-pentanediol;

[0017] Phase E: Symsitive 1609 and water-locking magnet A0;

[0018] Phase F: glycerol and glabridin 90;

[0019] The skin conditioner is a mixture of avocado tree fat extract, argania spinosa kernel oil and waste malt meal wax, the Symsitive 1609 is a mixture of 1,2-pentanediol and 4-tert-butyl cyclohexanol, and the water-locking magnet A0 is a mixture of sugar isomers, water, citric acid and sodium citrate.

[0020] In some embodiments, a ceramide composition, cholesterol, and linoleic acid are also included.

[0021] In some embodiments, in the moisturizing and repairing cream, the molar ratio of the ceramide composition, the cholesterol, and the linoleic acid is 3:1:1.

[0022] In some embodiments, the following raw materials are included, by weight percentage:

[0023] Phase A: balance deionized water, about 0.01% to about 0.1% disodium EDTA, about 0.1% to about 1% allantoin, and about 0.1% to about 1% p-hydroxyacetophenone;

[0024] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.1% to approximately 1%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.1% to approximately 1%;

[0025] Phase B: Glyceryl Stearate approximately 1% to approximately 5%, M68 Emulsifier approximately 1% to approximately 5%, Cetearyl Alcohol approximately 1% to approximately 5%, Dimethicone approximately 0.1% to approximately 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.1% to approximately 1%, Olea Europaea (Olive) Fruit Oil approximately 0.1% to approximately 1%, Squalane approximately 0.1% to approximately 1%, Skin Conditioning Agents approximately 1% to approximately 5%, Caprylic / Capric Triglyceride approximately 1% to approximately 5%;

[0026] Phase B1: about 1% to about 5% diethylhexyl carbonate, about 0.01% to about 0.1% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0027] Phase B2: caprylic / capric triglyceride about 1% to about 5%, ceramide composition about 0.1% to about 0.2%;

[0028] Phase C: about 1% to about 5% deionized water, about 0.01% to about 0.1% aminomethyl propanol;

[0029] Phase D: about 0.1% to about 1% of Glycyrrhiza inflata root extract, about 1% to about 5% of 1,2-pentanediol;

[0030] Phase E: Symsitive 1609 approximately 1% to approximately 5%, Moisture-Locking Magnet A0 approximately 1% to approximately 5%, Cholesterol approximately 0.001% to approximately 0.005%, Linoleic Acid approximately 0.001% to approximately 0.005%;

[0031] Phase F: about 1% to about 5% glycerol, about 0.0001% to about 0.0005% glabridin 90.

[0032] In some embodiments, the composition is composed of the following materials:

[0033] Phase A: deionized water, disodium EDTA, allantoin, and p-hydroxyacetophenone;

[0034] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer and Acrylates / C10-30 Alkyl Acrylate Crosspolymer;

[0035] Phase B: Glyceryl Stearate, M68 Emulsifier, Cetearyl Alcohol, Dimethicone, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, Olea Europaea (Olive) Fruit Oil, Squalane, Skin Conditioning Agents and Caprylic / Capric Triglyceride;

[0036] Phase B1: diethylhexyl carbonate and pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0037] Phase C: deionized water and aminomethyl propanol;

[0038] Phase D: Glycyrrhiza inflata root extract and 1,2-pentanediol;

[0039] Phase E: Symsitive 1609 and water-locking magnet A0;

[0040] Phase F: Glycerol and Glabridin 90.

[0041] In some embodiments, the composition is composed of the following raw materials, by weight percentage:

[0042] Phase A: balance deionized water, about 0.01% to about 0.1% disodium EDTA, about 0.1% to about 1% allantoin, and about 0.1% to about 1% p-hydroxyacetophenone;

[0043] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.1% to approximately 1%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.1% to approximately 1%;

[0044] Phase B: Glyceryl Stearate approximately 1% to approximately 5%, M68 Emulsifier approximately 1% to approximately 5%, Cetearyl Alcohol approximately 1% to approximately 5%, Dimethicone approximately 0.1% to approximately 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.1% to approximately 1%, Olea Europaea (Olive) Fruit Oil approximately 0.1% to approximately 1%, Squalane approximately 0.1% to approximately 1%, Skin Conditioning Agents approximately 1% to approximately 5%, Caprylic / Capric Triglyceride approximately 1% to approximately 5%;

[0045] Phase B1: about 1% to about 5% diethylhexyl carbonate, about 0.01% to about 0.1% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0046] Phase C: about 1% to about 5% deionized water, about 0.01% to about 0.1% aminomethyl propanol;

[0047] Phase D: about 0.1% to about 1% of Glycyrrhiza inflata root extract, about 1% to about 5% of 1,2-pentanediol;

[0048] Phase E: Symsitive 1609 about 1% to about 5%, water-locking magnet A0 about 1% to about 5%;

[0049] Phase F: about 1% to about 5% glycerol, about 0.0001% to about 0.0005% glabridin 90.

[0050] In some embodiments, the composition is composed of the following raw materials, by weight percentage:

[0051] Phase A: deionized water (approximately 77.8698%), disodium EDTA (approximately 0.02%), allantoin (approximately 0.2%), and p-hydroxyacetophenone (approximately 0.5%);

[0052] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.15%;

[0053] Phase B: Glyceryl Stearate approximately 1%, M68 Emulsifier approximately 2%, Cetearyl Alcohol approximately 2%, Dimethicone approximately 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.2%, Olea Europaea (Olive) Fruit Oil approximately 0.2%, Squalane approximately 0.2%, Skin Conditioner approximately 1%, Caprylic / Capric Triglyceride approximately 1%;

[0054] Phase B1: about 2% diethylhexyl carbonate, about 0.05% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0055] Phase C: about 2% deionized water, about 0.06% aminomethyl propanol;

[0056] Phase D: approximately 0.1% of Glycyrrhiza inflata root extract, approximately 2% of 1,2-pentanediol;

[0057] Phase E: Symsitive 1609 about 1%, water-locking magnet A0 about 2%;

[0058] Phase F: approximately 3% glycerol, approximately 0.0002% glabridin 90.

[0059] In some embodiments, the composition is composed of the following raw materials, by weight percentage:

[0060] Phase A: deionized water (approximately 73.2698%), disodium EDTA (approximately 0.02%), allantoin (approximately 0.2%), and p-hydroxyacetophenone (approximately 0.5%);

[0061] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.15%;

[0062] Phase B: Glyceryl Stearate approximately 1%, M68 Emulsifier approximately 2%, Cetearyl Alcohol approximately 2%, Dimethicone approximately 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.5%, Olea Europaea (Olive) Fruit Oil approximately 0.5%, Squalane approximately 0.2%, Skin Conditioner approximately 3%, Caprylic / Capric Triglyceride approximately 2%;

[0063] Phase B1: about 2% diethylhexyl carbonate, about 0.05% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0064] Phase C: about 2% deionized water, about 0.06% aminomethyl propanol;

[0065] Phase D: approximately 0.1% of Glycyrrhiza inflata root extract, approximately 2% of 1,2-pentanediol;

[0066] Phase E: Symsitive 1609 about 1%, water-locking magnet A0 about 3%;

[0067] Phase F: approximately 3% glycerol, approximately 0.0002% glabridin 90.

[0068] In some embodiments, the composition is composed of the following raw materials, by weight percentage:

[0069] Phase A: about 65.4698% deionized water, about 0.02% disodium EDTA, about 0.2% allantoin, and about 0.5% p-hydroxyacetophenone;

[0070] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.15%;

[0071] Phase B: Glyceryl Stearate approximately 2%, M68 Emulsifier approximately 1%, Cetearyl Alcohol approximately 5%, Dimethicone approximately 0.5%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.3%, Olea Europaea (Olive) Fruit Oil approximately 0.6%, Squalane approximately 0.2%, Skin Conditioner approximately 5%, Caprylic / Capric Triglyceride approximately 5%;

[0072] Phase B1: about 3% diethylhexyl carbonate, about 0.05% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0073] Phase C: about 2% deionized water, about 0.06% aminomethyl propanol;

[0074] Phase D: approximately 0.5% of Glycyrrhiza inflata root extract, approximately 2% of 1,2-pentanediol;

[0075] Phase E: Symsitive 1609 about 2%, water-locking magnet A0 about 1%;

[0076] Phase F: approximately 3% glycerol, approximately 0.0002% glabridin 90.

[0077] In some embodiments, the composition is composed of the following raw materials, by weight percentage:

[0078] Phase A: deionized water (approximately 69.8698%), disodium EDTA (approximately 0.02%), allantoin (approximately 0.2%), and p-hydroxyacetophenone (approximately 0.5%);

[0079] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.15%;

[0080] Phase B: Glyceryl Stearate approximately 1%, M68 Emulsifier approximately 2%, Cetearyl Alcohol approximately 3%, Dimethicone approximately 0.2%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.5%, Olea Europaea (Olive) Fruit Oil approximately 0.3%, Squalane approximately 0.5%, Skin Conditioner approximately 2%, Caprylic / Capric Triglyceride approximately 2%;

[0081] Phase B1: about 5% diethylhexyl carbonate, about 0.05% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0082] Phase C: about 2% deionized water, about 0.06% aminomethyl propanol;

[0083] Phase D: approximately 0.2% of Glycyrrhiza inflata root extract, approximately 2% of 1,2-pentanediol;

[0084] Phase E: Symsitive 1609 about 2%, water-locking magnet A0 about 3%;

[0085] Phase F: approximately 3% glycerol, approximately 0.0002% glabridin 90.

[0086] In some embodiments, the skin conditioning agent is a mixture of shea butter extract, argania spinosa kernel oil, and spent wheat germ meal wax in a weight ratio of about (3-8):(3-5):1.

[0087] A method for preparing a moisturizing repair cream with soothing effect comprises the following steps:

[0088] S1. Clean the production equipment and related weighing containers, disinfect them and set them aside;

[0089] S2. Accurately weigh all ingredients in the formula, place them in clean and sterilized containers, and place them in the material preparation cart after verification;

[0090] S3, prefabricate various raw materials;

[0091] S4. Add the components of phase A into the emulsifying pot in sequence, stir at a frequency of about 15Hz-about 35Hz, raise the temperature to about 80℃-85℃, and stir thoroughly to dissolve completely;

[0092] S5. Start the emulsifier and rotate forward at about 3000 rpm. Add the various items of phase A1 into the emulsifier in sequence and stir homogenously until they are completely dispersed and dissolved.

[0093] S6. Add all ingredients of phase B into the oil phase pot, stir at a speed of about 200 rpm to about 500 rpm, raise the temperature to about 80°C to about 85°C, and stir thoroughly to dissolve completely;

[0094] S7. Add the treated B1 phase into the emulsification pot, and then vacuum operate to about -0.05 MPa. Pump the B phase raw material into the emulsification pot, turn on the reverse rotation at about 3400 rpm and homogenize for about 8 minutes. Stir at a constant temperature of about 80°C to about 85°C for about 15 minutes until defoaming is completed;

[0095] S8. Start cooling; cool to about 60℃±2℃, add the dispersed phase C into the emulsifier, and stir to disperse evenly;

[0096] S9. Cool to about 40℃±2℃, add dissolved phases D, F and E into the emulsifier, stir and disperse thoroughly;

[0097] S10. Cool to below about 38°C. After passing preliminary inspection, filter the material with a filter cloth of about 100-200 mesh and store it in a static room.

[0098] S11, semi-finished product inspection; filling and packaging;

[0099] S12. Finished product inspection; storage.

[0100] In some embodiments, S3, prefabrication, comprises the following steps:

[0101] a: Reserve about 0.5% deionized water, stir and heat to about 80℃-85℃, then cool to room temperature for later use;

[0102] b: Mix all ingredients of phase B1, heat and stir to dissolve completely and set aside;

[0103] c. Use about 0.5% of the reserved deionized water to mix with phase C and stir until evenly dispersed;

[0104] d: Mix all ingredients in phase D, heat and stir until completely dissolved;

[0105] e: Mix and stir all the ingredients of phase F until completely dissolved and set aside.

[0106] The details of one or more embodiments of the present application are set forth in the description below. Other features, objects, and advantages of the present application will become apparent from the description and claims. DETAILED DESCRIPTION

[0107] The following will be combined with the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the embodiments described are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments of the present application, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of this application.

[0108] The first aspect of the present application provides a moisturizing repair cream with soothing effect, comprising the following ingredients:

[0109] Phase A: deionized water, disodium EDTA (disodium ethylenediaminetetraacetic acid), allantoin, and p-hydroxyacetophenone;

[0110] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer (Ammonium Acryloyldimethyltaurate / Vinyl Pyrrolidone Copolymer) and Acrylates / C10-30 Alkyl Acrylate Crosspolymer;

[0111] Phase B: Glyceryl Stearate, M68 Emulsifier (Cetyl Glucoside), Cetearyl Alcohol, Dimethicone, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, Olea Europaea (Olive) Fruit Oil, Squalane, Skin Conditioning Agents and Caprylic / Capric Triglyceride;

[0112] Phase B1: diethylhexyl carbonate and pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0113] Phase C: deionized water and aminomethyl propanol;

[0114] Phase D: Glycyrrhiza inflata root extract and 1,2-pentanediol;

[0115] Phase E: Symsitive 1609 and water-locking magnet A0;

[0116] Phase F: glycerol and glabridin 90;

[0117] The skin conditioner is a mixture of avocado tree fat extract, argania spinosa kernel oil and waste malt meal wax, the Symsitive 1609 is a mixture of 1,2-pentanediol and 4-tert-butyl cyclohexanol, and the water-locking magnet A0 is a mixture of sugar isomers, water, citric acid and sodium citrate.

[0118] It is understood that dimethicone (and) dimethicone / vinyl dimethicone crosspolymer refers to a composite composition consisting of dimethicone and dimethicone / vinyl dimethicone crosspolymer.

[0119] In some embodiments, the moisturizing and repairing cream further comprises a ceramide composition, cholesterol, and linoleic acid.

[0120] In some embodiments, in the moisturizing and repairing cream, the molar ratio of the ceramide composition, cholesterol, and linoleic acid is 3:1:1.

[0121] In some embodiments, the ceramide composition includes ceramide EOP (ceramide 9), ceramide NS / ceramide NG (ceramide 2), ceramide NP (ceramide 3), ceramide AS (ceramide 5), and ceramide AP (ceramide 6).

[0122] In some embodiments, the moisturizing and repairing cream comprises the following ingredients, calculated by weight percentage:

[0123] Phase A: balance deionized water, about 0.01% to about 0.1% disodium EDTA, about 0.1% to about 1% allantoin, and about 0.1% to about 1% p-hydroxyacetophenone;

[0124] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.1% to approximately 1%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.1% to approximately 1%;

[0125] Phase B: Glyceryl Stearate approximately 1% to approximately 5%, M68 Emulsifier approximately 1% to approximately 5%, Cetearyl Alcohol approximately 1% to approximately 5%, Dimethicone approximately 0.1% to approximately 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.1% to approximately 1%, Olea Europaea (Olive) Fruit Oil approximately 0.1% to approximately 1%, Squalane approximately 0.1% to approximately 1%, Skin Conditioning Agents approximately 1% to approximately 5%, Caprylic / Capric Triglyceride approximately 1% to approximately 5%;

[0126] Phase B1: about 1% to about 5% diethylhexyl carbonate, about 0.01% to about 0.1% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0127] Phase B2: caprylic / capric triglyceride about 1% to about 5%, ceramide composition about 0.1% to about 0.2%;

[0128] Phase C: about 1% to about 5% deionized water, about 0.01% to about 0.1% aminomethyl propanol;

[0129] Phase D: about 0.1% to about 1% of Glycyrrhiza inflata root extract, about 1% to about 5% of 1,2-pentanediol;

[0130] Phase E: Symsitive 1609 (approximately 1% to 5%), Moisture-Locking Magnet A0 (approximately 1% to 5%), Cholesterol (approximately 0.001% to 0.005%), and Linoleic Acid (approximately 0.001% to 0.005%).

[0131] Phase F: about 1% to about 5% glycerol, about 0.0001% to about 0.0005% glabridin 90.

[0132] In some other embodiments, the moisturizing repair cream is composed of the following ingredients, by weight percentage:

[0133] Phase A: balance deionized water, about 0.01% to about 0.1% disodium EDTA, about 0.1% to about 1% allantoin, and about 0.1% to about 1% p-hydroxyacetophenone;

[0134] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer approximately 0.1% to approximately 1%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer approximately 0.1% to approximately 1%;

[0135] Phase B: Glyceryl Stearate approximately 1% to approximately 5%, M68 Emulsifier approximately 1% to approximately 5%, Cetearyl Alcohol approximately 1% to approximately 5%, Dimethicone approximately 0.1% to approximately 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer approximately 0.1% to approximately 1%, Olea Europaea (Olive) Fruit Oil approximately 0.1% to approximately 1%, Squalane approximately 0.1% to approximately 1%, Skin Conditioning Agents approximately 1% to approximately 5%, Caprylic / Capric Triglyceride approximately 1% to approximately 5%;

[0136] Phase B1: about 1% to about 5% diethylhexyl carbonate, about 0.01% to about 0.1% pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate;

[0137] Phase C: about 1% to about 5% deionized water, about 0.01% to about 0.1% aminomethyl propanol;

[0138] Phase D: about 0.1% to about 1% of Glycyrrhiza inflata root extract, about 1% to about 5% of 1,2-pentanediol;

[0139] Phase E: Symsitive 1609 about 1% to about 5%, water-locking magnet A0 about 1% to about 5%;

[0140] Phase F: about 1% to about 5% glycerol, about 0.0001% to about 0.0005% glabridin 90.

[0141] It can be understood that the weight percentages of the above components all refer to the weight percentages in the moisturizing repair cream.

[0142] In some embodiments, the skin conditioning agent is a mixture of shea butter extract, argania spinosa kernel oil, and spent wheat germ meal wax in a weight ratio of (3-8):(3-5):1.

[0143] The principle of the moisturizing repair cream of this application is that T cell subsets include Th1 and Th2, and the onset of eczema is related to the imbalance of T cell subsets. According to the "Guidelines for the Diagnosis and Treatment of Atopic Dermatitis in China (2020 Edition)", Th2-type inflammation is the basic characteristic of AD, and interleukin-4 (IL-4) and interleukin-13 (IL-13) are important cytokines that mediate the pathogenesis of AD. Th2 cells mainly secrete IL-4, interleukin-5 (IL-5), IL-13, interleukin-25 (IL-25), interleukin-31 (IL-31), etc. Abnormal secretion of Th2 cytokines is closely related to the occurrence, development and prognosis of eczema. Th2-related proinflammatory factors: TSLP and IL-33. TSLP is an epithelial cell-derived factor and an IL-7 analog. It is involved in the imbalance of Th2 immune response and is a key "initiator" of Th2 immune response. It is mainly expressed in epithelial cells and keratinocytes. The primary sources of IL-33+ST2+ cells are keratinocytes and endothelial cells. The IL-33-ST2 pathway plays a crucial role in immune inflammatory responses. High IL-33 levels are significantly associated with exfoliation and xerosis, and can downregulate filaggrin in keratinocytes, thereby affecting the skin's barrier function. IL-33 is emerging as a key factor in allergic inflammation, such as asthma and eczema. IL-33 can upregulate the NF-κB p65 subunit in the nucleus, promoting inflammation in endothelial cells and acting as a proinflammatory cytokine by binding to the receptor ST2. Th2 cytokines include IL-25, IL-4, IL-5, and IL-13.

[0144] Inflammatory factors in eczema also include TRPV-1 (capsaicin receptor). TRPV-1 is primarily expressed in afferent neurons, keratinocytes, dendritic cells, and mast cells. Certain itch and pain modulators, such as capsaicin, eicosanoids, histamine, and ATP, can activate or sensitize TRPV-1, contributing to the development of itch in AD. PDE4D and PDE4B, the primary isoforms of PDE4 (phosphodiesterase 4) that regulate inflammation, play a crucial role in activating the tumor necrosis factor alpha (TNF-α) response. TNF-α is a proinflammatory cytokine, typically secreted and synthesized by monocytes and macrophages, and participates in a range of inflammatory processes. Mast cell degranulation in AD may be caused by increased expression of the intercellular adhesion molecule (ICAM-1) in keratinocytes induced by TNF-α and histamine. IL-1 (interleukin-1) is a cytokine that plays a central role in local and systemic inflammatory responses. IL-1 expression positively correlates with the severity of inflammation and can be used as a clinical indicator of inflammatory disease severity and treatment efficacy. After epidermal activation, IL-1 is released, which then promotes the occurrence of skin inflammatory response by inducing multiple cytokines, pro-inflammatory mediators and adhesion molecules.

[0145] In this application:

[0146] Avocado butter extract, extracted from the fruit of the avocado tree, contains the same natural moisturizing factor as the moisturizing component extracted from the sebaceous glands, making it considered one of the most effective natural moisturizers and conditioners. Avocados are a highly nutritious fruit, rich in vitamins, fat, and protein, and high in sodium, potassium, magnesium, and calcium. The nutritional value of extracted avocado butter is similar to that of wheat germ oil, containing unsaturated fatty acids, linoleic acid, and a rich source of B vitamins and vitamin E. It also contains phytosterols, a valuable skincare ingredient.

[0147] Benefits of avocado butter: 1) Moisturizing and hydrating. A natural plant-based emulsifier, it forms a milky barrier on the surface of the skin, accelerating the penetration of nutrients and providing powerful moisture-locking and moisturizing properties. 2) Antioxidant. Avocado butter contains vitamins A, E, B6, and protein, making it a natural antioxidant. 3) UV protection. Cinnamates, used in sunscreens, protect against UV damage. The natural latex in avocado butter can also prevent skin allergies caused by sun exposure.

[0148] The anti-inflammatory effect of avocado oil extract is mainly achieved by inhibiting the levels of cytokines such as nuclear factor κB (NF-κB), inducible nitric oxide synthase (iNOS), adhesion molecules (intercellular adhesion molecule-1 and vascular cell adhesion molecule-1), tumor necrosis factor (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8), while promoting the production of interleukin-4 (IL-4) and interleukin-10 (IL-10).

[0149] Verma et al. investigated the anti-inflammatory mechanism of a methanolic extract of shea butter resin using lipopolysaccharide (LPS)-induced murine macrophage cell line J774. Their results demonstrated that treatment with the methanolic extract significantly reduced LPS-induced levels of nitric oxide (NO), TNF-α, interleukin-1β (IL-1β), and interleukin-12 (IL-12) in a dose-dependent manner. Furthermore, the proinflammatory enzymes iNOS and COX-2 (cyclooxygenase-2) were also inhibited. This anti-inflammatory effect was attributed to the methanolic extract's effective inhibition of phosphorylation of the inhibitory protein of NF-κB (IκBα), thereby suppressing the expression of messenger RNA (mRNA) and protein of iNOS, COX-2, TNF-α, IL-1β, and IL-12. These findings provide a direct molecular explanation for the anti-inflammatory mechanism of the methanolic extract of shea butter.

[0150] 4-tert-Butylcyclohexanol

[0151] Itch is a common manifestation of eczema. TRPV-1 is expressed on skin sensory nerve fibers, mast cells, and keratinocytes, and is involved in the normal physiological functions of the skin and the occurrence of diseases. TRPV1 receptor agonists and antagonists are both considered as potential analgesics. TRPV1 receptor antagonists show the key to blocking nociceptive conduction. By selectively blocking the action of TRPV1 receptors, they avoid the side effects of agonists that are difficult to separate efficacy and toxicity, especially attenuating acute thermal nociception and reducing thermal hyperalgesia in various inflammatory models. 4-tert-Butylcyclohexanol, as a TRPV-1 antagonist, mainly exerts analgesic effects by inhibiting voltage-sensitive calcium ion channels, blocking the depolarization caused by calcium ion influx, while inhibiting the actions of nicotine, voltage-gated calcium channels, and TRPM8 (a receptor that can be activated by cold), while avoiding the hyperthermia side effects caused by other antagonists. Therefore, 4-tert-Butylcyclohexanol can effectively soothe sensitive skin, thereby inhibiting tingling and burning sensations.

[0152] Sugar isomers

[0153] Saccharide isomers are made by converting edible corn sugar into a glycoconjugate similar to the natural moisturizing factor (NMF) found in the stratum corneum. They bind to the ε-amino group of lysine in keratin from corneocytes. This unique binding mechanism prevents the active ingredient from eluting and continuously improves moisturizing properties until removed by the natural desquamation process. Saccharide isomers have a very similar carbohydrate composition to that found in human keratin, providing deep skin moisturization for up to 72 hours. Therefore, the moisture-locking magnet promotes moisturization and hydration of the stratum corneum in the short term, thereby improving desquamation in the medium and long term.

[0154] Licorice Extract

[0155] In the early 1980s, studies revealed that dysregulation of inflammatory responses in AD patients is associated with increased phosphodiesterase (PDE) activity. PDE4, a key phosphodiesterase subtype, is the largest member of the PDE family that hydrolyzes cyclic AMP and plays a crucial role in the cyclic AMP signaling pathway. PDE4A is closely associated with cell proliferation and apoptosis, PDE4B with cellular inflammation and lipid metabolism, and PDE4D, whose expression is significantly elevated in both AD and psoriasis groups. The mRNA expression levels of various PDE4 subtypes differ between AD and psoriasis lesions, suggesting a significant role in the pathogenesis of AD. Licorice extract from Glycyrrhiza inflata contains a special active ingredient: licochalcone A, a PDE4 inhibitor with a high safety profile that can reduce the release of proinflammatory cytokines and alleviate erythema.

[0156] As a PDE4 inhibitor, Glycyrrhiza inflata extract addresses the onset and progression of AD through multiple pathways: inhibiting the release of multiple inflammatory mediators / cytokines, such as IL-1β and IL-6, and suppressing the expression of multiple inflammatory cell genes, such as COX-2 and iNOS, thereby playing a significant anti-inflammatory role and improving skin barrier function. Glycyrrhiza inflata extract is commonly used in skin care to reduce erythema, such as in the prevention and treatment of erythematous, inflammatory, allergic, or autoimmune skin conditions. It also has an emollient effect and can enhance skin immunity in the treatment of skin injuries.

[0157] Ceramide composition, cholesterol and linoleic acid

[0158] The structure of the skin's stratum corneum is a complex of proteins and lipids, often described as a "brick and mortar" structure. Protein-rich keratinocytes are embedded in the intercellular matrix, similar to bricks, providing the stratum corneum with mechanical strength. The mortar, consisting primarily of non-polar lipids, is composed of ceramides (CERs), cholesterol (CHOLs), and free fatty acids (FFAs).

[0159] Studies have shown that the reduced barrier function of AD skin is associated with abnormal epidermal lipid metabolism. Measurements of non-lesional skin in AD patients revealed a significant decrease in long-chain ceramides, with ceramide 1 and ceramide 3 showing the most significant reductions. Analysis of the epidermis revealed a significant decrease in ceramide 1 and ceramide 9, which is associated with an abnormal ceramide-to-cholesterol ratio, leading to a breakdown in barrier function.

[0160] The ceramide composition of the present application includes ceramide EOP (ceramide 9), ceramide NS / ceramide NG (ceramide 2), ceramide NP (ceramide 3), ceramide AS (ceramide 5) and ceramide AP (ceramide 6), which can fully supplement ceramide.

[0161] In some embodiments, in the moisturizing repair cream, the molar ratio of ceramide composition: cholesterol: linoleic acid is 3:1:1, which is the same as the ratio of the skin stratum corneum, and can better enhance the skin barrier function of patients with atopic dermatitis.

[0162] Benefits of this application's moisturizing repair cream:

[0163] 1. In this application, a variety of soothing ingredients are compounded and combined with emulsifiers, emollients, moisturizers and skin conditioners to prepare a moisturizing repair cream that can soothe itching, eliminate inflammation, moisturize, and repair damaged skin. It can maintain the stability of the water content of the stratum corneum, improve the hydration of the skin, effectively protect and restore the skin barrier function, and reduce skin dryness, roughness, itching, etc.

[0164] 2. In this application, multiple emollient ingredients are combined to create a synergistic effect, providing excellent emollient properties. This plays a supporting role in the treatment of atopic dermatitis, forming a thin oil film on the skin surface, rebuilding the chemical / physical barrier, and preventing water loss, thereby achieving moisturizing and emollient effects, preventing recurrence of AD, and improving quality of life. It can also repair dry, rough skin, relieve skin stress, and leave the hands smooth, soft, and hydrated.

[0165] 3. This application targets the inflammatory factors of eczema and specifically selects raw materials to inhibit them. Among them, water-locking magnets can reduce TEWL (transepidermal water loss), and licorice chalcone A can inhibit the release of various inflammatory mediators / cytokines such as IL-1β and IL-6, and inhibit the expression of various inflammatory cell genes such as COX-2 and iNOS. It has many therapeutic and improvement effects on the symptoms of dermatitis and eczema.

[0166] The second aspect of the present application provides a method for preparing the above-mentioned moisturizing repair cream with soothing effect, comprising the following steps:

[0167] S1. Clean the production equipment and related weighing containers, disinfect them and set them aside;

[0168] S2. Accurately weigh all ingredients in the formula, place them in clean and sterilized containers, and place them in the material preparation cart after verification;

[0169] S3, prefabricate various raw materials;

[0170] S4. Add the components of phase A into the emulsifying pot in sequence, stir at a frequency of about 15Hz-about 35Hz, raise the temperature to about 80℃-85℃, and stir thoroughly to dissolve completely;

[0171] S5. Start the emulsifier and rotate forward at about 3000 rpm. Add the various items of phase A1 into the emulsifier in sequence and stir homogenously until they are completely dispersed and dissolved.

[0172] S6. Add all ingredients of phase B into the oil phase pot, stir at a speed of about 200 rpm to about 500 rpm, raise the temperature to about 80°C to about 85°C, and stir thoroughly to dissolve completely;

[0173] S7. Add the treated B1 phase into the emulsification pot, and then vacuum operate to about -0.05 MPa. Pump the B phase raw material into the emulsification pot, turn on the reverse rotation at about 3400 rpm and homogenize for about 8 minutes. Stir at a constant temperature of about 80°C to about 85°C for about 15 minutes until defoaming is completed;

[0174] S8. Start cooling; cool to about 60℃±2℃, add the dispersed phase C into the emulsifier, and stir to disperse evenly;

[0175] S9. Cool to about 40℃±2℃, add dissolved phases D, F and E into the emulsifier, stir and disperse thoroughly;

[0176] S10, cooling to below about 38°C, filtering the material with a filter cloth of about 100-200 mesh after passing the preliminary inspection, and storing it in a static room;

[0177] S11, semi-finished product inspection; filling and packaging;

[0178] S12. Finished product inspection; storage.

[0179] It is understandable that the above only provides a relatively detailed preparation method of the moisturizing repair cream, but is not limited thereto. It only needs to be able to evenly mix the various components in the moisturizing repair cream.

[0180] In some embodiments, S3, prefabrication, comprises the following steps:

[0181] a: Reserve 0.5% deionized water, stir and heat to 80-85℃, then cool to room temperature for later use;

[0182] b: Mix all ingredients of phase B1, heat and stir to dissolve completely and set aside;

[0183] c. Use the reserved 0.5% deionized water to mix with phase C and stir until evenly dispersed;

[0184] d: Mix all ingredients in phase D, heat and stir until completely dissolved;

[0185] e: Mix and stir all the ingredients of phase F until completely dissolved and set aside.

[0186] In order to make the purpose and advantages of the present application clearer, the moisturizing repair cream with soothing effect of the present application and its effects are further described in detail below with reference to specific examples. It should be understood that the specific examples described here are only used to explain the present application and shall not be used to limit the present application. The following examples do not include other components except unavoidable impurities unless otherwise specified. The drugs and instruments used in the examples are all conventionally selected in the art unless otherwise specified. The experimental methods for which specific conditions are not specified in the examples shall be implemented according to conventional conditions, such as the conditions described in the literature, books, or the methods recommended by the manufacturer.

[0187] Example 1:

[0188] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0189] Phase A: deionized water 77.8698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0190] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0191] Phase B: Glyceryl Stearate 1%, M68 Emulsifier 2%, Cetearyl Alcohol 2%, Dimethicone 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.2%, Olea Europaea (Olive) Fruit Oil 0.2%, Squalane 0.2%, Skin Conditioner 1%, Caprylic / Capric Triglyceride 1%;

[0192] Phase B1: diethylhexyl carbonate 2%, pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate 0.05%;

[0193] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0194] Phase D: Glycyrrhiza inflata root extract 0.1%, 1,2-pentanediol 2%;

[0195] Phase E: Symsitive 1609 1%, Water-Locking Magnet A0 2%;

[0196] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0197] Example 2:

[0198] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0199] Phase A: deionized water 73.2698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0200] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0201] Phase B: Glyceryl Stearate 1%, M68 Emulsifier 2%, Cetearyl Alcohol 2%, Dimethicone 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.5%, Olea Europaea (Olive) Fruit Oil 0.5%, Squalane 0.2%, Skin Conditioner 3%, Caprylic / Capric Triglyceride 2%;

[0202] Phase B1: diethylhexyl carbonate 2%, pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate 0.05%;

[0203] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0204] Phase D: Glycyrrhiza inflata root extract 0.1%, 1,2-pentanediol 2%;

[0205] Phase E: Symsitive 1609 1%, Water-Locking Magnet A0 3%;

[0206] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0207] Example 3:

[0208] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0209] Phase A: deionized water 65.4698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0210] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0211] Phase B: Glyceryl Stearate 2%, M68 Emulsifier 1%, Cetearyl Alcohol 5%, Dimethicone 0.5%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.3%, Olea Europaea (Olive) Fruit Oil 0.6%, Squalane 0.2%, Skin Conditioner 5%, Caprylic / Capric Triglyceride 5%;

[0212] Phase B1: diethylhexyl carbonate 3%, pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate 0.05%;

[0213] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0214] Phase D: Glycyrrhiza inflata root extract 0.5%, 1,2-pentanediol 2%;

[0215] Phase E: Symsitive 1609 2%, Water-Locking Magnet A0 1%;

[0216] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0217] Example 4:

[0218] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0219] Phase A: deionized water 69.8698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0220] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0221] Phase B: Glyceryl Stearate 1%, M68 Emulsifier 2%, Cetearyl Alcohol 3%, Dimethicone 0.2%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.5%, Olea Europaea (Olive) Fruit Oil 0.3%, Squalane 0.5%, Skin Conditioner 2%, Caprylic / Capric Triglyceride 2%;

[0222] Phase B1: diethylhexyl carbonate 5%, pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate 0.05%;

[0223] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0224] Phase D: Glycyrrhiza inflata root extract 0.2%, 1,2-pentanediol 2%;

[0225] Phase E: Symsitive 1609 2%, Water-Locking Magnet A0 3%;

[0226] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0227] Example 5:

[0228] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0229] Phase A: deionized water 72.8698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0230] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0231] Phase B: Glyceryl Stearate 1%, M68 Emulsifier 2%, Cetearyl Alcohol 1%, Dimethicone 0.5%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.8%, Olea Europaea (Olive) Fruit Oil 0.8%, Squalane 0.1%, Skin Conditioner 4%, Caprylic / Capric Triglyceride 3%;

[0232] Phase B1: diethylhexyl carbonate 2%, pentaerythritol tetra(bis-tert-butyl hydroxyhydrocinnamate) 0.05%;

[0233] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0234] Phase D: Glycyrrhiza inflata root extract 0.1%, 1,2-pentanediol 2%;

[0235] Phase E: Symsitive 1609 1%, Water-Locking Magnet A0 2%;

[0236] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0237] Example 6:

[0238] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0239] Phase A: deionized water 71.6698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0240] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0241] Phase B: Glyceryl Stearate 1.5%, M68 Emulsifier 1.5%, Cetearyl Alcohol 2%, Dimethicone 0.3%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 1%, Olea Europaea (Olive) Fruit Oil 1%, Squalane 0.5%, Skin Conditioner 3%, Caprylic / Capric Triglyceride 4%;

[0242] Phase B1: diethylhexyl carbonate 3%, pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate 0.05%;

[0243] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0244] Phase D: Glycyrrhiza inflata root extract 0.1%, 1,2-pentanediol 2%;

[0245] Phase E: Symsitive 1609 1%, Water-Locking Magnet A0 1%;

[0246] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0247] Example 7:

[0248] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0249] Phase A: deionized water 70.7698%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0250] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0251] Phase B: Glyceryl Stearate 3%, M68 Emulsifier 1%, Cetearyl Alcohol 2%, Dimethicone 0.5%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.5%, Olea Europaea (Olive) Fruit Oil 0.5%, Squalane 0.1%, Skin Conditioner 3%, Caprylic / Capric Triglyceride 5%;

[0252] Phase B1: diethylhexyl carbonate 2%, pentaerythritol tetra(bis-tert-butyl hydroxyhydrocinnamate) 0.05%,

[0253] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0254] Phase D: Glycyrrhiza inflata root extract 0.2%, 1,2-pentanediol 2%;

[0255] Phase E: Symsitive 1609 2%, Water-Locking Magnet A0 1%;

[0256] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0257] Example 8

[0258] A moisturizing and repairing cream with soothing effect, composed of the following raw materials in percentage by weight:

[0259] Phase A: deionized water 71.0598%, disodium EDTA 0.02%, allantoin 0.2%, p-hydroxyacetophenone 0.5%;

[0260] Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer 0.45%, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.15%;

[0261] Phase B: Glyceryl Stearate 1%, M68 Emulsifier 2%, Cetearyl Alcohol 2%, Dimethicone 1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 0.5%, Olea Europaea (Olive) Fruit Oil 0.5%, Squalane 0.2%, Skin Conditioner 3%, Caprylic / Capric Triglyceride 2%;

[0262] Phase B1: diethylhexyl carbonate 2%, pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate 0.05%;

[0263] Phase B2: Caprylic / Capric Triglyceride 2%, Ceramide Composition Approximately 0.2%;

[0264] Phase C: 2% deionized water, 0.06% aminomethyl propanol;

[0265] Phase D: Glycyrrhiza inflata root extract 0.1%, 1,2-pentanediol 2%;

[0266] Phase E: Symsitive 1609 1%, water-locking magnet A0 3%, cholesterol about 0.005%, linoleic acid about 0.005%;

[0267] Phase F: glycerol 3%, glabridin 90 0.0002%.

[0268] Test Example 1

[0269] The moisturizing repair cream with soothing effect prepared in Example 1-8 was tested. The test items included the presence of odor, shelf life, bacteria detection, heavy metal detection and toxicity detection. The results are shown in Table 1 below.

[0270] Table 1

[0271] The results of the test indicate that the moisturizing and repairing cream with soothing effect prepared in this application complies with the national cosmetic hygiene standards of China.

[0272] Test Example 2

[0273] The moisturizing repair cream with soothing effect prepared in Examples 1-8 was tested. The test items included thermal stability, light stability, antiseptic challenge test, soothing effect, repair effect and moisturizing property. The results are shown in Table 2 below.

[0274] Table 2

[0275] In Table 2, "ok" indicates that the performance meets the requirements. "×" indicates that the performance does not meet the requirements. "+," "++," and "+++" represent three different levels of performance. A "+" indicates that the performance is achieved, and the more "+"s there are, the better the performance.

[0276] From the analysis of the test results, it can be seen that the moisturizing repair cream with soothing effect prepared in the present application has skin repair effect and soothing effect, has good moisturizing properties, and repairs over-cleansed skin.

[0277] It should be noted that the test examples in this application are based on the "Cosmetic Hygiene Standards" issued by China in 2007 and the "Cosmetic Safety Technical Standards" issued in 2015 as reference standards. The detection method refers to GB / T 13531.1-2008, and the anti-corrosion challenge test refers to the 28-day anti-corrosion single challenge test method recommended by PCPC (Personal Care Products Association of the United States, formerly known as CTFA). The soothing effect and cleansing effect are tested using the test method in Chapter 7 Human Safety Test Methods in the "Cosmetic Safety Technical Standards 2015 Edition" issued by China in 2015.

[0278] Throughout this specification, references to "one embodiment," "example," and the like indicate that a specific feature, structure, material, or characteristic described in connection with that embodiment or example is included in at least one embodiment or example of the present invention. In this specification, schematic representations of these terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.

[0279] The technical features of the above-mentioned embodiments can be combined arbitrarily. In order to make the description concise, not all possible combinations of the technical features in the above-mentioned embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0280] The above-described embodiments merely represent several implementation methods of the present application. While the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the patent application. It should be noted that a person of ordinary skill in the art may make various modifications and improvements without departing from the spirit of the present application, and these modifications and improvements fall within the scope of protection of the present application. Therefore, the scope of protection of the present patent application shall be determined by the appended claims.

Claims

1. A moisturizing repair cream with soothing effect, characterized in that: Including the following ingredients: Phase A: deionized water, disodium EDTA, allantoin, and p-hydroxyacetophenone; Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer and Acrylates / C10-30 Alkyl Acrylate Crosspolymer; Phase B: Glyceryl Stearate, M68 Emulsifier, Cetearyl Alcohol, Dimethicone, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, Olea Europaea (Olive) Fruit Oil, Squalane, Skin Conditioning Agents and Caprylic / Capric Triglyceride; Phase B1: diethylhexyl carbonate and pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate; Phase C: deionized water and aminomethyl propanol; Phase D: Glycyrrhiza inflata root extract and 1,2-pentanediol; Phase E: Symsitive 1609 and water-locking magnet A0; Phase F: glycerol and glabridin 90; The skin conditioner is a mixture of avocado tree fat extract, argania spinosa kernel oil and waste malt meal wax, the Symsitive 1609 is a mixture of 1,2-pentanediol and 4-tert-butyl cyclohexanol, and the water-locking magnet A0 is a mixture of sugar isomers, water, citric acid and sodium citrate.

2. The moisturizing repair cream with soothing effect according to claim 1, characterized in that: Also included are ceramide compositions, cholesterol and linoleic acid.

3. The moisturizing repair cream with soothing effect according to claim 2, characterized in that: In the moisturizing repair cream, the molar ratio of the ceramide composition, the cholesterol and the linoleic acid is 3:1:

1.

4. The moisturizing repair cream with soothing effect according to claim 2 or 3, characterized in that: In terms of weight percentage, the following raw materials are included: Phase A: balance deionized water, about 0.01% to about 0.1% disodium EDTA, about 0.1% to about 1% allantoin, and about 0.1% to about 1% p-hydroxyacetophenone; Phase A1: about 0.1% to about 1% of ammonium acryloyldimethyltaurate / VP copolymer, about 0.1% to about 1% of acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer; Phase B: about 1% to about 5% of glyceryl stearate, about 1% to about 5% of M68 emulsifier, about 1% to about 5% of cetearyl alcohol, about 0.1% to about 1% of polydimethylsiloxane, about 0.1% to about 1% of dimethicone, about 0.1% to about 1% of dimethicone (and) polydimethylsiloxane / vinyl dimethicone crosspolymer, about 0.1% to about 1% of olive fruit oil, about 0.1% to about 1% of squalane, about 1% to about 5% of skin conditioning agent, about 1% to about 5% of caprylic / capric triglyceride; Phase B1: about 1% to about 5% of diethylhexyl carbonate, about 0.01% to about 0.1% of pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate); Phase B2: about 1% to about 5% caprylic / capric triglyceride, about 0.1% to about 0.2% ceramide composition; Phase C: about 1% to about 5% deionized water, about 0.01% to about 0.1% aminomethyl propanol; Phase D: about 0.1% to about 1% of Glycyrrhiza inflata root extract, about 1% to about 5% of 1,2-pentanediol; Phase E: about 1% to about 5% of Symsitive 1609, about 1% to about 5% of water-locking magnet A0, about 0.001% to about 0.005% of cholesterol, and about 0.001% to about 0.005% of linoleic acid; Phase F: about 1% to about 5% glycerol, about 0.0001% to about 0.0005% glabridin 90.

5. The moisturizing repair cream with soothing effect according to claim 1, characterized in that: It is composed of the following raw materials: Phase A: deionized water, disodium EDTA, allantoin, and p-hydroxyacetophenone; Phase A1: Ammonium Acryloyldimethyltaurate / VP Copolymer and Acrylates / C10-30 Alkyl Acrylate Crosspolymer; Phase B: Glyceryl Stearate, M68 Emulsifier, Cetearyl Alcohol, Dimethicone, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, Olea Europaea (Olive) Fruit Oil, Squalane, Skin Conditioning Agents and Caprylic / Capric Triglyceride; Phase B1: diethylhexyl carbonate and pentaerythritol tetrakis-di-tert-butyl hydroxyhydrocinnamate; Phase C: deionized water and aminomethyl propanol; Phase D: Glycyrrhiza inflata root extract and 1,2-pentanediol; Phase E: Symsitive 1609 and water-locking magnet A0; Phase F: Glycerol and Glabridin 90.

6. The moisturizing repair cream with soothing effect according to claim 5, characterized in that: In terms of weight percentage, it is composed of the following raw materials: Phase A: balance deionized water, about 0.01% to about 0.1% disodium EDTA, about 0.1% to about 1% allantoin, and about 0.1% to about 1% p-hydroxyacetophenone; Phase A1: about 0.1% to about 1% of ammonium acryloyldimethyltaurate / VP copolymer, about 0.1% to about 1% of acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer; Phase B: about 1% to about 5% of glyceryl stearate, about 1% to about 5% of M68 emulsifier, about 1% to about 5% of cetearyl alcohol, about 0.1% to about 1% of polydimethylsiloxane, about 0.1% to about 1% of dimethicone, about 0.1% to about 1% of dimethicone (and) polydimethylsiloxane / vinyl dimethicone crosspolymer, about 0.1% to about 1% of olive fruit oil, about 0.1% to about 1% of squalane, about 1% to about 5% of skin conditioning agent, about 1% to about 5% of caprylic / capric triglyceride; Phase B1: about 1% to about 5% diethylhexyl carbonate, about 1% to about 5% pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate) 0.01% - about 0.1%; Phase C: about 1% to about 5% deionized water, about 0.01% to about 0.1% aminomethyl propanol; Phase D: about 0.1% to about 1% of Glycyrrhiza inflata root extract, about 1% to about 5% of 1,2-pentanediol; Phase E: Symsitive 1609 about 1% - about 5%, water-locking magnet A0 about 1% - about 5%; Phase F: about 1% to about 5% glycerol, about 0.0001% to about 0.0005% glabridin 90.

7. The moisturizing repair cream with soothing effect according to claim 6, characterized in that: In terms of weight percentage, it is composed of the following raw materials: Phase A: about 77.8698% deionized water, about 0.02% disodium EDTA, about 0.2% allantoin, and about 0.5% p-hydroxyacetophenone; Phase A1: about 0.45% ammonium acryloyldimethyltaurate / VP copolymer, about 0.15% acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer; Phase B: about 1% of glyceryl stearate, about 2% of M68 emulsifier, about 2% of cetearyl alcohol, about 1% of polydimethylsiloxane, about 0.2% of dimethicone (and) polydimethylsiloxane / vinyl dimethicone crosspolymer, about 0.2% of olive fruit oil, about 0.2% of squalane, about 1% of skin conditioning agent, about 1% of caprylic / capric triglyceride; Phase B1: about 2% diethylhexyl carbonate, about 0.05% pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate); Phase C: about 2% deionized water, about 0.06% aminomethyl propanol; Phase D: about 0.1% of Glycyrrhiza inflata root extract, about 2% of 1,2-pentanediol; Phase E: Symsitive 1609 about 1%, water-locking magnet A0 about 2%; Phase F: about 3% glycerol, about 0.0002% glabridin 90.

8. The moisturizing repair cream with soothing effect according to claim 6, characterized in that: In terms of weight percentage, it is composed of the following raw materials: Phase A: about 73.2698% deionized water, about 0.02% disodium EDTA, about 0.2% allantoin, and about 0.5% p-hydroxyacetophenone; Phase A1: about 0.45% ammonium acryloyldimethyltaurate / VP copolymer, about 0.15% acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer; Phase B: about 1% of glyceryl stearate, about 2% of M68 emulsifier, about 2% of cetearyl alcohol, about 1% of polydimethylsiloxane, about 0.5% of dimethicone (and) polydimethylsiloxane / vinyl dimethicone crosspolymer, about 0.5% of olive fruit oil, about 0.2% of squalane, about 3% of skin conditioning agent, about 2% of caprylic / capric triglyceride; Phase B1: about 2% diethylhexyl carbonate, about 0.05% pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate); Phase C: about 2% deionized water, about 0.06% aminomethyl propanol; Phase D: about 0.1% of Glycyrrhiza inflata root extract, about 2% of 1,2-pentanediol; Phase E: Symsitive 1609 about 1%, water-locking magnet A0 about 3%; Phase F: about 3% glycerol, about 0.0002% glabridin 90.

9. The moisturizing repair cream with soothing effect according to claim 6, characterized in that: In terms of weight percentage, it is composed of the following raw materials: Phase A: about 65.4698% deionized water, about 0.02% disodium EDTA, about 0.2% allantoin, and about 0.5% p-hydroxyacetophenone; Phase A1: about 0.45% ammonium acryloyldimethyltaurate / VP copolymer, about 0.15% acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer; Phase B: about 2% of glyceryl stearate, about 1% of M68 emulsifier, about 5% of cetearyl alcohol, about 0.5% of polydimethylsiloxane, about 0.3% of dimethicone (and) polydimethylsiloxane / vinyl dimethicone crosspolymer, about 0.6% of olive fruit oil, about 0.2% of squalane, about 5% of skin conditioning agent, about 5% of caprylic / capric triglyceride; Phase B1: about 3% diethylhexyl carbonate, about 0.05% pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate); Phase C: about 2% deionized water, about 0.06% aminomethyl propanol; Phase D: about 0.5% of Glycyrrhiza inflata root extract, about 2% of 1,2-pentanediol; Phase E: Symsitive 1609 about 2%, water-locking magnet A0 about 1%; Phase F: about 3% glycerol, about 0.0002% glabridin 90.

10. The moisturizing repair cream with soothing effect according to claim 6, characterized in that: In terms of weight percentage, it is composed of the following raw materials: Phase A: about 69.8698% deionized water, about 0.02% disodium EDTA, about 0.2% allantoin, and about 0.5% p-hydroxyacetophenone; Phase A1: about 0.45% ammonium acryloyldimethyltaurate / VP copolymer, about 0.15% acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer; Phase B: about 1% of glyceryl stearate, about 2% of M68 emulsifier, about 3% of cetearyl alcohol, about 0.2% of polydimethylsiloxane, about 0.5% of dimethicone (and) polydimethylsiloxane / vinyl dimethicone crosspolymer, about 0.3% of olive fruit oil, about 0.5% of squalane, about 2% of skin conditioning agent, about 2% of caprylic / capric triglyceride; Phase B1: about 5% diethylhexyl carbonate, about 0.05% pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate); Phase C: about 2% deionized water, about 0.06% aminomethyl propanol; Phase D: about 0.2% of Glycyrrhiza inflata root extract, about 2% of 1,2-pentanediol; Phase E: Symsitive 1609 about 2%, water-locking magnet A0 about 3%; Phase F: about 3% glycerol, about 0.0002% glabridin 90.

11. The moisturizing repair cream with soothing effect according to any one of claims 1 to 10, characterized in that: The skin conditioning agent is a mixture of avocado oil extract, argania spinosa kernel oil and waste malt meal wax in a weight ratio of about (3-8):(3-5):

1.

12. The method for preparing the moisturizing repair cream with soothing effect according to any one of claims 1 to 11, characterized in that: The following steps are involved: S1. Clean the production equipment and related weighing containers, disinfect and set aside; S2. Accurately weigh various raw materials in the formula, place them in clean and sterilized containers, and place them in the material preparation vehicle after verification; S3, prefabricate various raw materials; S4. Add the items of phase A into the emulsifying pot in sequence, stir at a frequency of about 15 Hz to about 35 Hz, raise the temperature to about 80°C to 85°C, and stir thoroughly to dissolve completely; S5. Start the emulsifier and rotate it forward at about 3000 rpm for homogenization. Add each item of phase A1 into the emulsifier in sequence and homogenize and stir until it is completely dispersed and dissolved. S6. Add all the ingredients of phase B into the oil phase pot, stir at a speed of about 200 rpm to about 500 rpm, raise the temperature to about 80°C to about 85°C, and stir thoroughly to dissolve completely; S7, put the treated B1 phase into the emulsification pot, and then vacuum operate to about -0.05MPa, pump the B phase raw material into the emulsification pot, turn on the reverse rotation at about 3400rpm for homogenization for about 8 minutes, and stir at a constant temperature of about 80℃-about 85℃ for about 15 minutes until defoaming is completed; S8, start cooling; cool to about 60℃±2℃, put the dispersed C phase into the emulsifying pot, stir and disperse evenly; S9. Cool to about 40℃±2℃, put dissolved phases D, F and E into the emulsifying pot, stir and disperse them evenly; S10, cooling to below about 38°C, filtering the material with a filter cloth of about 100-200 mesh after passing the preliminary inspection, and storing it in a static room; S11, semi-finished product inspection; filling and packaging; S12, finished product inspection; storage.

13. The method for preparing the moisturizing repair cream with soothing effect according to claim 12, characterized in that: S3, prefab, The following steps are involved: a: Reserve about 0.5% of deionized water, stir and heat to about 80℃-85℃, then cool to room temperature for later use; b: Mix all the ingredients of phase B1, heat, stir and dissolve until completely dissolved; c: Use about 0.5% of the reserved deionized water to mix with phase C and stir to disperse evenly for later use; d: Mix all the ingredients in phase D, heat and stir until completely dissolved and set aside; e: Mix and stir all ingredients of phase F until completely dissolved and set aside.